Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 15 | 2024 | 1154 | 3.220 |
Why?
|
Sarcoma | 8 | 2024 | 1791 | 2.030 |
Why?
|
Vascular Malformations | 6 | 2021 | 468 | 1.480 |
Why?
|
Lipoma | 2 | 2023 | 292 | 1.290 |
Why?
|
Fibrosarcoma | 4 | 2023 | 308 | 1.140 |
Why?
|
Myofibromatosis | 2 | 2023 | 27 | 1.060 |
Why?
|
Hemangioma | 4 | 2023 | 727 | 0.990 |
Why?
|
Sarcoma, Clear Cell | 2 | 2022 | 72 | 0.940 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2023 | 102 | 0.840 |
Why?
|
Myxoma | 1 | 2023 | 114 | 0.840 |
Why?
|
Fibromatosis, Aggressive | 1 | 2023 | 125 | 0.810 |
Why?
|
Bone Neoplasms | 7 | 2024 | 2525 | 0.790 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 218 | 0.770 |
Why?
|
Granuloma, Plasma Cell | 1 | 2022 | 80 | 0.760 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 42 | 0.760 |
Why?
|
Sarcoma, Synovial | 2 | 2020 | 152 | 0.720 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 180 | 0.720 |
Why?
|
Hemangioendothelioma, Epithelioid | 4 | 2023 | 53 | 0.680 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2023 | 2423 | 0.670 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2019 | 12 | 0.660 |
Why?
|
Child | 53 | 2024 | 80086 | 0.650 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2018 | 117 | 0.650 |
Why?
|
Vascular Neoplasms | 1 | 2020 | 166 | 0.650 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2018 | 33 | 0.630 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1624 | 0.620 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1605 | 0.620 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2020 | 225 | 0.620 |
Why?
|
Hamartoma | 2 | 2017 | 235 | 0.580 |
Why?
|
Neoplasms, Connective and Soft Tissue | 3 | 2023 | 34 | 0.570 |
Why?
|
Fibroma | 1 | 2018 | 190 | 0.560 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4509 | 0.540 |
Why?
|
Neck | 1 | 2021 | 735 | 0.530 |
Why?
|
Child, Preschool | 33 | 2024 | 42209 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2024 | 3631 | 0.520 |
Why?
|
Gene Rearrangement | 5 | 2024 | 1125 | 0.520 |
Why?
|
Infant | 26 | 2024 | 36183 | 0.500 |
Why?
|
Head | 1 | 2021 | 924 | 0.490 |
Why?
|
Arteriovenous Malformations | 4 | 2020 | 397 | 0.450 |
Why?
|
Specimen Handling | 2 | 2020 | 703 | 0.440 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2018 | 0.430 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2013 | 35 | 0.430 |
Why?
|
Mutation | 13 | 2024 | 30025 | 0.410 |
Why?
|
Pathology, Clinical | 1 | 2016 | 375 | 0.410 |
Why?
|
Neurofibrosarcoma | 2 | 2023 | 27 | 0.390 |
Why?
|
Receptor, trkA | 3 | 2023 | 159 | 0.380 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2891 | 0.380 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2013 | 124 | 0.380 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 232 | 0.380 |
Why?
|
Repressor Proteins | 2 | 2021 | 2978 | 0.370 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 215 | 0.370 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2021 | 67 | 0.360 |
Why?
|
RNA-Binding Protein EWS | 2 | 2024 | 210 | 0.350 |
Why?
|
Adolescent | 34 | 2024 | 88196 | 0.340 |
Why?
|
Carcinoma | 1 | 2021 | 2328 | 0.340 |
Why?
|
Biopsy, Fine-Needle | 2 | 2022 | 1118 | 0.340 |
Why?
|
Subcutaneous Tissue | 2 | 2021 | 132 | 0.330 |
Why?
|
Female | 61 | 2024 | 391875 | 0.320 |
Why?
|
Male | 49 | 2024 | 360035 | 0.310 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4319 | 0.300 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2020 | 331 | 0.300 |
Why?
|
Kidney Neoplasms | 2 | 2022 | 4241 | 0.300 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2020 | 1741 | 0.290 |
Why?
|
Humans | 83 | 2024 | 760437 | 0.290 |
Why?
|
Fasciitis | 2 | 2019 | 67 | 0.280 |
Why?
|
Immunohistochemistry | 9 | 2024 | 11070 | 0.270 |
Why?
|
Neurofibromatosis 1 | 2 | 2023 | 560 | 0.270 |
Why?
|
Infant, Newborn | 11 | 2024 | 26280 | 0.270 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2416 | 0.250 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1051 | 0.240 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2019 | 455 | 0.240 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2024 | 43 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9267 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2024 | 2509 | 0.230 |
Why?
|
Nevus, Blue | 1 | 2024 | 43 | 0.230 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2024 | 77 | 0.220 |
Why?
|
Oncogene Fusion | 2 | 2021 | 81 | 0.220 |
Why?
|
Brain Neoplasms | 2 | 2022 | 9003 | 0.220 |
Why?
|
Diagnosis, Differential | 8 | 2024 | 12969 | 0.220 |
Why?
|
Referral and Consultation | 1 | 2016 | 3596 | 0.210 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2022 | 40 | 0.210 |
Why?
|
Bone Marrow | 1 | 2013 | 2907 | 0.210 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2023 | 184 | 0.210 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 181 | 0.210 |
Why?
|
Neoplasm Proteins | 2 | 2024 | 3610 | 0.210 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5815 | 0.210 |
Why?
|
Dyskeratosis Congenita | 1 | 2023 | 73 | 0.210 |
Why?
|
Nephroma, Mesoblastic | 1 | 2022 | 24 | 0.200 |
Why?
|
Nose Neoplasms | 2 | 2015 | 249 | 0.200 |
Why?
|
Endodermal Sinus Tumor | 1 | 2022 | 53 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2024 | 316 | 0.200 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2021 | 36 | 0.200 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2023 | 168 | 0.190 |
Why?
|
Necrosis | 2 | 2023 | 1604 | 0.190 |
Why?
|
Hemangioendothelioma | 1 | 2022 | 111 | 0.190 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 176 | 0.190 |
Why?
|
Diarrhea, Infantile | 1 | 2021 | 101 | 0.190 |
Why?
|
Lip | 1 | 2022 | 197 | 0.190 |
Why?
|
Hypertension, Portal | 1 | 2023 | 226 | 0.180 |
Why?
|
Malabsorption Syndromes | 1 | 2021 | 135 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4369 | 0.180 |
Why?
|
Granuloma, Pyogenic | 1 | 2020 | 47 | 0.170 |
Why?
|
Homeodomain Proteins | 3 | 2024 | 2413 | 0.170 |
Why?
|
Endothelial Cells | 3 | 2022 | 3541 | 0.170 |
Why?
|
Disorders of Sex Development | 1 | 2021 | 129 | 0.170 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 897 | 0.170 |
Why?
|
Myofibroma | 1 | 2019 | 45 | 0.170 |
Why?
|
Codon | 1 | 2021 | 602 | 0.170 |
Why?
|
Teratoma | 1 | 2022 | 402 | 0.160 |
Why?
|
Prognosis | 9 | 2020 | 29551 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4575 | 0.160 |
Why?
|
Oncogenes | 2 | 2022 | 1223 | 0.160 |
Why?
|
Genital Neoplasms, Female | 1 | 2024 | 532 | 0.160 |
Why?
|
Sarcoma, Kaposi | 1 | 2022 | 374 | 0.160 |
Why?
|
Metabolism, Inborn Errors | 1 | 2021 | 286 | 0.160 |
Why?
|
Neurofibromin 1 | 1 | 2020 | 190 | 0.160 |
Why?
|
Eye Abnormalities | 1 | 2021 | 241 | 0.150 |
Why?
|
Cartilage Diseases | 1 | 2020 | 156 | 0.150 |
Why?
|
beta Catenin | 1 | 2023 | 1040 | 0.150 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 186 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2022 | 304 | 0.150 |
Why?
|
WT1 Proteins | 1 | 2018 | 184 | 0.150 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 157 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 350 | 0.150 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2023 | 732 | 0.150 |
Why?
|
Solitary Fibrous Tumors | 1 | 2018 | 67 | 0.140 |
Why?
|
Stem Cell Niche | 1 | 2021 | 345 | 0.140 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 491 | 0.140 |
Why?
|
Lymphatic Diseases | 1 | 2018 | 320 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 285 | 0.140 |
Why?
|
Scalp | 1 | 2019 | 389 | 0.140 |
Why?
|
Wnt Proteins | 1 | 2021 | 718 | 0.140 |
Why?
|
Atrial Septum | 1 | 2017 | 60 | 0.140 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2017 | 114 | 0.130 |
Why?
|
Adipocytes | 1 | 2023 | 1192 | 0.130 |
Why?
|
Reoperation | 2 | 2024 | 4300 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2024 | 952 | 0.130 |
Why?
|
Young Adult | 16 | 2024 | 59068 | 0.130 |
Why?
|
Adult | 22 | 2024 | 220781 | 0.130 |
Why?
|
Appendix | 1 | 2017 | 109 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1127 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2017 | 255 | 0.130 |
Why?
|
Leg Injuries | 1 | 2017 | 179 | 0.130 |
Why?
|
Muscular Diseases | 1 | 2020 | 553 | 0.130 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 706 | 0.130 |
Why?
|
GTP Phosphohydrolases | 1 | 2018 | 516 | 0.120 |
Why?
|
Exons | 1 | 2021 | 2392 | 0.120 |
Why?
|
Endemic Diseases | 1 | 2016 | 190 | 0.120 |
Why?
|
Skull | 1 | 2019 | 818 | 0.120 |
Why?
|
Rhabdomyosarcoma | 1 | 2018 | 358 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2022 | 978 | 0.120 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2016 | 329 | 0.120 |
Why?
|
Upper Extremity | 1 | 2019 | 656 | 0.120 |
Why?
|
Diarrhea | 1 | 2021 | 1319 | 0.110 |
Why?
|
Glycoproteins | 1 | 2021 | 2207 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 326 | 0.110 |
Why?
|
Meningioma | 1 | 2021 | 1218 | 0.100 |
Why?
|
Neoplasms | 4 | 2024 | 22083 | 0.100 |
Why?
|
Liver Diseases | 1 | 2021 | 1296 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2332 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1248 | 0.100 |
Why?
|
Chordoma | 1 | 2015 | 346 | 0.100 |
Why?
|
Lower Extremity | 1 | 2020 | 1199 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2017 | 523 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1090 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1114 | 0.100 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2017 | 594 | 0.100 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2052 | 0.090 |
Why?
|
Elasticity Imaging Techniques | 1 | 2016 | 390 | 0.090 |
Why?
|
Lung | 2 | 2022 | 9973 | 0.090 |
Why?
|
Histones | 2 | 2023 | 2577 | 0.090 |
Why?
|
Pancreatitis | 1 | 2018 | 1096 | 0.090 |
Why?
|
Osteochondroma | 1 | 2011 | 44 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6471 | 0.090 |
Why?
|
Genomics | 5 | 2024 | 5806 | 0.090 |
Why?
|
Fatty Liver | 1 | 2016 | 782 | 0.080 |
Why?
|
DNA Methylation | 2 | 2023 | 4383 | 0.080 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2011 | 418 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5662 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 1 | 2017 | 1755 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 637 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2024 | 10425 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39078 | 0.070 |
Why?
|
Malaria, Falciparum | 1 | 2016 | 1076 | 0.070 |
Why?
|
Molecular Biology | 2 | 2022 | 580 | 0.070 |
Why?
|
Retrospective Studies | 10 | 2024 | 80430 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3434 | 0.070 |
Why?
|
Molecular Targeted Therapy | 3 | 2024 | 2805 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6033 | 0.070 |
Why?
|
Syndrome | 2 | 2024 | 3267 | 0.070 |
Why?
|
Biopsy | 4 | 2020 | 6765 | 0.070 |
Why?
|
Plasmodium falciparum | 1 | 2016 | 1741 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4879 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1393 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1388 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4923 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2911 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10538 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5075 | 0.060 |
Why?
|
Liver | 2 | 2021 | 7531 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3421 | 0.060 |
Why?
|
Middle Aged | 10 | 2024 | 220382 | 0.060 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5359 | 0.060 |
Why?
|
Endothelium, Lymphatic | 1 | 2024 | 63 | 0.060 |
Why?
|
Epithelioid Cells | 1 | 2024 | 60 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5704 | 0.060 |
Why?
|
Primary Graft Dysfunction | 1 | 2024 | 111 | 0.050 |
Why?
|
Angiomyolipoma | 1 | 2024 | 186 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20078 | 0.050 |
Why?
|
Leukoplakia, Oral | 1 | 2023 | 77 | 0.050 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2024 | 201 | 0.050 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2021 | 12 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12429 | 0.050 |
Why?
|
S100 Proteins | 1 | 2022 | 218 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2023 | 256 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15627 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7849 | 0.050 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2022 | 168 | 0.050 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2024 | 694 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6086 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2024 | 556 | 0.040 |
Why?
|
Salivary Glands | 1 | 2022 | 229 | 0.040 |
Why?
|
Gene Fusion | 1 | 2023 | 354 | 0.040 |
Why?
|
Genitalia | 1 | 2021 | 113 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8519 | 0.040 |
Why?
|
Base Sequence | 2 | 2022 | 12449 | 0.040 |
Why?
|
Public Opinion | 1 | 2024 | 484 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 634 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16585 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 298 | 0.040 |
Why?
|
Sclerotherapy | 1 | 2019 | 182 | 0.040 |
Why?
|
STAT6 Transcription Factor | 1 | 2018 | 193 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2021 | 600 | 0.040 |
Why?
|
Aged | 6 | 2021 | 168840 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1075 | 0.040 |
Why?
|
Tongue | 1 | 2020 | 403 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11900 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13312 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6813 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8522 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 733 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 621 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3590 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2018 | 658 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 41366 | 0.030 |
Why?
|
Reticulin | 1 | 2015 | 19 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1595 | 0.030 |
Why?
|
Recurrence | 2 | 2020 | 8466 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23397 | 0.030 |
Why?
|
Fetal Heart | 1 | 2017 | 281 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.030 |
Why?
|
North America | 1 | 2018 | 1275 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15257 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2024 | 2870 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2642 | 0.030 |
Why?
|
Ultrasonography | 2 | 2017 | 5966 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 2803 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3806 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1863 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12698 | 0.030 |
Why?
|
Transcription Factors | 2 | 2024 | 12121 | 0.030 |
Why?
|
Mitosis | 1 | 2018 | 1186 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2163 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20551 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2017 | 816 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2021 | 2571 | 0.020 |
Why?
|
Graft Rejection | 1 | 2024 | 4438 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3734 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2017 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6908 | 0.020 |
Why?
|
Ulna | 1 | 2011 | 134 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2637 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3026 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5794 | 0.020 |
Why?
|
Boston | 1 | 2022 | 9326 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7996 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 64591 | 0.020 |
Why?
|
Fibrosis | 1 | 2015 | 2048 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3510 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16945 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36362 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4903 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3818 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2247 | 0.020 |
Why?
|
Genetic Variation | 1 | 2018 | 6570 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11096 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 58859 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13484 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11526 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10746 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12785 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18379 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168253 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14661 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17854 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54339 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81402 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29831 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26063 | 0.010 |
Why?
|